**Question:** Which of the following drugs is not used for the treatment of Alzheimer's disease:

A. Donepezil (Aricept)
B. Rivastigmine (Exelon)
C. Galantamine (Razadyne)
D. Memantine (Ebixa)

**Core Concept:** Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, memory loss, and behavioral abnormalities. The primary treatment approach for AD involves cholinesterase inhibitors (CIs) and N-methyl-D-aspartate (NMDA) receptor antagonists.

**Why the Correct Answer is Right:** Memantine (option D) is a non-competitive NMDA receptor antagonist, which works by modulating glutamate neurotransmission and reducing neuronal excitotoxicity. Memantine is commonly used in combination with cholinesterase inhibitors to provide a dual therapy approach for AD management.

**Why Each Wrong Option is Incorrect:**

A. Donepezil (Aricept, option A): It is a reversible cholinesterase inhibitor that enhances the levels of acetylcholine, a neurotransmitter involved in memory and learning processes. Donepezil is widely used in the management of mild to moderate AD.

B. Rivastigmine (Exelon, option B): Similar to donepezil, rivastigmine is a cholinesterase inhibitor that increases acetylcholine levels in the brain. It is commonly used to manage mild to moderate AD.

C. Galantamine (Razadyne, option C): Galantamine is another cholinesterase inhibitor that enhances acetylcholine levels in the brain, particularly helpful in managing mild to moderate AD.

**Core Concept (Revised):** Alzheimer's disease is typically treated using a combination of cholinesterase inhibitors and NMDA receptor antagonists, such as memantine, to provide a dual therapy approach.

**Core Concept (Expanded):** Alzheimer's disease (AD) is a complex neurodegenerative disorder involving amyloid-beta and tau protein deposition, neuroinflammation, and neuronal dysfunction. Cholinesterase inhibitors like donepezil, rivastigmine, and galantamine target acetylcholine neurotransmission, while memantine, a NMDA receptor antagonist, modulates glutamate neurotransmission and reduces neuronal excitotoxicity.

**Why Each Wrong Option is Incorrect:**

A. Donepezil, Rivastigmine, and Galantamine (options A, B, and C) are all cholinesterase inhibitors that target acetylcholine neurotransmission, while memantine (option D) is an NMDA receptor antagonist that modulates glutamate neurotransmission and reduces neuronal excitotoxicity.

**Why Each Wrong Option is Right:**

A. Donepezil, Rivastigmine, and Galantamine (options A, B, and C) are all cholinesterase inhibitors that target acetylcholine neurotransmission, while memantine (option